Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05581511 · ClinicalTrials.gov registry record
Natural History Study of Cutaneous Neurofibromas in People With NF1
A clinical trial of Neurofibromatosis 1 and Neurofibromatosis Type 1, sponsored by Johns Hopkins University.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05581511 is a study of Neurofibromatosis 1 and Neurofibromatosis Type 1 that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 500 participants, below the 1,015-participant average among 24 other Neurofibromatosis 1 trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05581511, a study of Neurofibromatosis 1 and Neurofibromatosis Type 1, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
People diagnosed with NF1 may develop cutaneous neurofibromas, also known as cNFs. These benign tumors can cause discomfort and affect a person's quality of life. Researchers at Johns Hopkins are studying how cNF tumors form, grow and change over time. This information may help doctors in the future, provide early interventions and improve quality of life for NF1 patients. Researchers will also explore a new way of monitoring cNF with 3D camera technology. People of all ages with NF1, living in the United States, are invited to participate in this important research study.
Conditions Studied
Interventions
- OTHER Evaluation of the natural history of cutaneous neurofibromas
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-06-28 |
| Est. Completion | 2029-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05581511
The ClinicalTrials.gov registry entry for NCT05581511 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,015-participant average among 24 other Neurofibromatosis 1 trials with a reported enrollment target (51% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Neurofibromatosis 1 appearing as the primary indexed condition, and to 1 intervention - of which Evaluation of the natural history of cutaneous neurofibromas is the first listed.
NCT05581511 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05581511 about?
NCT05581511 is a clinical study titled "Natural History Study of Cutaneous Neurofibromas in People With NF1". People diagnosed with NF1 may develop cutaneous neurofibromas, also known as cNFs. These benign tumors can cause discomfort and affect a person's quality of life. Researchers at Johns Hopkins are studying how cNF tumors form, grow and change over time. This information may help doctors in the future...
What is the current status of trial NCT05581511?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2021-06-28. Estimated completion is 2029-06-30.
What conditions does trial NCT05581511 study?
This clinical trial studies the following conditions: Neurofibromatosis 1, Neurofibromatosis Type 1, Cutaneous Neurofibroma, Neurofibromatosis (Nonmalignant).
What interventions are being tested in trial NCT05581511?
The interventions under investigation include: Evaluation of the natural history of cutaneous neurofibromas (OTHER).
Who is sponsoring clinical trial NCT05581511?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05581511 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurofibromatosis 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
RECRUITING · NA
-
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
RECRUITING · NA
-
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
RECRUITING
-
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RECRUITING · Phase 1
-
Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
RECRUITING · NA
-
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.